Fortress Biotech Inc
NASDAQ:FBIO
Income Statement
Earnings Waterfall
Fortress Biotech Inc
Revenue
|
84.5m
USD
|
Cost of Revenue
|
-26.7m
USD
|
Gross Profit
|
57.9m
USD
|
Operating Expenses
|
-197.1m
USD
|
Operating Income
|
-139.2m
USD
|
Other Expenses
|
70.6m
USD
|
Net Income
|
-68.7m
USD
|
Income Statement
Fortress Biotech Inc
Dec-2013 | Mar-2014 | Jun-2014 | Sep-2014 | Dec-2014 | Mar-2015 | Jun-2015 | Sep-2015 | Dec-2015 | Mar-2016 | Jun-2016 | Sep-2016 | Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||||||||||||||||||||||||||||||||||
Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
1
N/A
|
1
N/A
|
1
+6%
|
1
+62%
|
1
+20%
|
3
+217%
|
4
+29%
|
16
+291%
|
61
+267%
|
109
+80%
|
155
+42%
|
17
-89%
|
(22)
N/A
|
(65)
-204%
|
(107)
-64%
|
27
N/A
|
27
+2%
|
30
+9%
|
34
+15%
|
37
+6%
|
43
+18%
|
43
+0%
|
43
-1%
|
46
+6%
|
44
-3%
|
53
+19%
|
64
+22%
|
69
+7%
|
81
+18%
|
82
+1%
|
78
-6%
|
76
-2%
|
64
-15%
|
63
-2%
|
81
+29%
|
85
+4%
|
|
Gross Profit | ||||||||||||||||||||||||||||||||||||||||||
Cost of Revenue |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(1)
|
(1)
|
(2)
|
(2)
|
(4)
|
(5)
|
(5)
|
(6)
|
(6)
|
(7)
|
(7)
|
(9)
|
(11)
|
(12)
|
(13)
|
(14)
|
(15)
|
(15)
|
(19)
|
(27)
|
(32)
|
(36)
|
(37)
|
(33)
|
(31)
|
(29)
|
(29)
|
(28)
|
(27)
|
|
Gross Profit |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
2
N/A
|
3
+49%
|
16
+452%
|
59
+278%
|
107
+81%
|
153
+42%
|
14
-91%
|
(26)
N/A
|
(71)
-170%
|
(113)
-60%
|
21
N/A
|
21
+1%
|
23
+8%
|
26
+15%
|
26
+1%
|
31
+17%
|
30
-2%
|
29
-3%
|
31
+7%
|
30
-5%
|
34
+14%
|
37
+11%
|
37
-2%
|
45
+22%
|
46
+2%
|
45
-1%
|
45
0%
|
35
-22%
|
34
-5%
|
53
+57%
|
58
+10%
|
|
Operating Income | ||||||||||||||||||||||||||||||||||||||||||
Operating Expenses |
(36)
|
(34)
|
(28)
|
(25)
|
(21)
|
(27)
|
(30)
|
(43)
|
(51)
|
(55)
|
(64)
|
(63)
|
(81)
|
(127)
|
(183)
|
(245)
|
(103)
|
(80)
|
(38)
|
9
|
(141)
|
(139)
|
(141)
|
(139)
|
(137)
|
(130)
|
(130)
|
(129)
|
(125)
|
(132)
|
(158)
|
(179)
|
(216)
|
(251)
|
(256)
|
(256)
|
(249)
|
(250)
|
(245)
|
(227)
|
(197)
|
|
Selling, General & Administrative |
(10)
|
(10)
|
(10)
|
(10)
|
(10)
|
(12)
|
(13)
|
(18)
|
(22)
|
(26)
|
(31)
|
(33)
|
(34)
|
(36)
|
(39)
|
(45)
|
(51)
|
(54)
|
(56)
|
(53)
|
(53)
|
(53)
|
(54)
|
(56)
|
(56)
|
(58)
|
(59)
|
(60)
|
(61)
|
(63)
|
(68)
|
(75)
|
(87)
|
(96)
|
(105)
|
(113)
|
(114)
|
(113)
|
(108)
|
(100)
|
(91)
|
|
Research & Development |
(26)
|
(24)
|
(19)
|
(15)
|
(10)
|
(15)
|
(16)
|
(26)
|
(30)
|
(29)
|
(33)
|
(30)
|
(35)
|
(36)
|
(41)
|
(49)
|
(52)
|
(69)
|
(73)
|
(77)
|
(87)
|
(86)
|
(87)
|
(83)
|
(81)
|
(73)
|
(71)
|
(70)
|
(64)
|
(69)
|
(89)
|
(104)
|
(129)
|
(145)
|
(141)
|
(143)
|
(135)
|
(138)
|
(137)
|
(127)
|
(106)
|
|
Other Operating Expenses |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(12)
|
(55)
|
(104)
|
(151)
|
0
|
43
|
92
|
139
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(10)
|
(10)
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Operating Income |
(36)
N/A
|
(34)
+5%
|
(28)
+16%
|
(25)
+11%
|
(21)
+18%
|
(26)
-27%
|
(29)
-11%
|
(43)
-47%
|
(51)
-18%
|
(54)
-6%
|
(61)
-14%
|
(59)
+3%
|
(66)
-11%
|
(68)
-4%
|
(76)
-12%
|
(93)
-21%
|
(90)
+3%
|
(106)
-18%
|
(109)
-2%
|
(104)
+4%
|
(120)
-15%
|
(118)
+1%
|
(118)
+0%
|
(113)
+5%
|
(111)
+2%
|
(100)
+10%
|
(100)
0%
|
(100)
-1%
|
(94)
+6%
|
(103)
-9%
|
(124)
-21%
|
(141)
-14%
|
(179)
-27%
|
(206)
-15%
|
(210)
-2%
|
(211)
0%
|
(204)
+3%
|
(215)
-6%
|
(211)
+2%
|
(174)
+18%
|
(139)
+20%
|
|
Pre-Tax Income | ||||||||||||||||||||||||||||||||||||||||||
Interest Income Expense |
(1)
|
(2)
|
(1)
|
(1)
|
0
|
1
|
2
|
0
|
(3)
|
(4)
|
(7)
|
(6)
|
(6)
|
(1)
|
1
|
(2)
|
(7)
|
(12)
|
(16)
|
(15)
|
(11)
|
(11)
|
(11)
|
(10)
|
(9)
|
(10)
|
(11)
|
(15)
|
(9)
|
(2)
|
23
|
34
|
24
|
18
|
(7)
|
(14)
|
(11)
|
(12)
|
(15)
|
(14)
|
(12)
|
|
Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
19
|
19
|
19
|
18
|
0
|
(0)
|
(0)
|
0
|
0
|
0
|
(10)
|
(10)
|
0
|
0
|
0
|
0
|
0
|
(7)
|
(7)
|
(7)
|
|
Total Other Income |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
0
|
(1)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
8
|
8
|
13
|
4
|
|
Pre-Tax Income |
(37)
N/A
|
(36)
+4%
|
(30)
+17%
|
(26)
+11%
|
(20)
+23%
|
(26)
-25%
|
(27)
-7%
|
(43)
-56%
|
(54)
-27%
|
(58)
-8%
|
(68)
-17%
|
(65)
+4%
|
(71)
-10%
|
(69)
+3%
|
(76)
-9%
|
(95)
-26%
|
(98)
-3%
|
(119)
-22%
|
(125)
-5%
|
(120)
+4%
|
(131)
-9%
|
(111)
+15%
|
(110)
+1%
|
(103)
+6%
|
(102)
+2%
|
(109)
-8%
|
(110)
-1%
|
(115)
-5%
|
(103)
+11%
|
(105)
-2%
|
(101)
+4%
|
(117)
-16%
|
(164)
-41%
|
(188)
-14%
|
(217)
-16%
|
(225)
-3%
|
(213)
+5%
|
(219)
-3%
|
(225)
-2%
|
(182)
+19%
|
(154)
+16%
|
|
Net Income | ||||||||||||||||||||||||||||||||||||||||||
Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
(0)
|
0
|
0
|
(0)
|
(0)
|
0
|
0
|
(1)
|
(1)
|
|
Income from Continuing Operations |
(37)
|
(36)
|
(30)
|
(26)
|
(20)
|
(26)
|
(27)
|
(43)
|
(54)
|
(58)
|
(68)
|
(65)
|
(71)
|
(69)
|
(76)
|
(95)
|
(98)
|
(119)
|
(125)
|
(120)
|
(131)
|
(111)
|
(110)
|
(103)
|
(102)
|
(109)
|
(110)
|
(115)
|
(103)
|
(105)
|
(101)
|
(117)
|
(165)
|
(188)
|
(218)
|
(225)
|
(214)
|
(220)
|
(225)
|
(183)
|
(154)
|
|
Income to Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
2
|
5
|
9
|
13
|
15
|
16
|
14
|
16
|
21
|
33
|
48
|
56
|
59
|
58
|
58
|
59
|
59
|
62
|
56
|
57
|
59
|
56
|
62
|
68
|
78
|
100
|
117
|
128
|
134
|
127
|
127
|
129
|
104
|
94
|
|
Net Income (Common) |
(37)
N/A
|
(36)
+4%
|
(30)
+17%
|
(26)
+11%
|
(20)
+23%
|
(25)
-23%
|
(27)
-6%
|
(40)
-51%
|
(48)
-21%
|
(49)
0%
|
(55)
-13%
|
(50)
+9%
|
(55)
-11%
|
(55)
+0%
|
(60)
-9%
|
(74)
-24%
|
(67)
+9%
|
(76)
-14%
|
(80)
-6%
|
(70)
+13%
|
(84)
-21%
|
(62)
+27%
|
(53)
+14%
|
(49)
+7%
|
(40)
+19%
|
(54)
-34%
|
(54)
0%
|
(57)
-5%
|
(47)
+18%
|
(43)
+8%
|
(33)
+23%
|
(38)
-16%
|
(65)
-68%
|
(74)
-14%
|
(93)
-27%
|
(97)
-4%
|
(87)
+11%
|
(98)
-14%
|
(102)
-3%
|
(84)
+17%
|
(69)
+19%
|
|
EPS (Diluted) |
-15.61
N/A
|
-14.92
+4%
|
-12.37
+17%
|
-11.02
+11%
|
-8.42
+24%
|
-9.75
-16%
|
-10.16
-4%
|
-15.25
-50%
|
-18.56
-22%
|
-18.4
+1%
|
-20.63
-12%
|
-18.54
+10%
|
-20.71
-12%
|
-20.39
+2%
|
-22.13
-9%
|
-27.16
-23%
|
-24.05
+11%
|
-26.82
-12%
|
-27.73
-3%
|
-23.3
+16%
|
-29.01
-25%
|
-14.52
+50%
|
-14.86
-2%
|
-13.02
+12%
|
-10.96
+16%
|
-12.69
-16%
|
-11.8
+7%
|
-11.18
+5%
|
-9.69
+13%
|
-7.97
+18%
|
-6.03
+24%
|
-7.09
-18%
|
-11.88
-68%
|
-12.52
-5%
|
-15.79
-26%
|
-16.31
-3%
|
-14.61
+10%
|
-13.6
+7%
|
-13.79
-1%
|
-11.24
+18%
|
-8.47
+25%
|